These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The preventative effects of vasodilating beta-blockers in cardiovascular disease. Raftery EB Eur Heart J; 1996 Apr; 17 Suppl B():30-8. PubMed ID: 8733069 [TBL] [Abstract][Full Text] [Related]
3. Effects of carvedilol in patients with impaired left ventricular function due to ischaemic heart disease. Lahiri A; Rodrigues EA; DasGupta P; Jain D; van der Does R; Raftery EB Z Kardiol; 1989; 78 Suppl 3():21-7. PubMed ID: 2573213 [TBL] [Abstract][Full Text] [Related]
4. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Krum H; Sackner-Bernstein JD; Goldsmith RL; Kukin ML; Schwartz B; Penn J; Medina N; Yushak M; Horn E; Katz SD Circulation; 1995 Sep; 92(6):1499-506. PubMed ID: 7664433 [TBL] [Abstract][Full Text] [Related]
5. Carvedilol versus verapamil in chronic stable angina: a multicentre trial. Hauf-Zachariou U; Blackwood RA; Gunawardena KA; O'Donnell JG; Garnham S; Pfarr E Eur J Clin Pharmacol; 1997; 52(2):95-100. PubMed ID: 9174677 [TBL] [Abstract][Full Text] [Related]
6. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study. Olsen SL; Gilbert EM; Renlund DG; Taylor DO; Yanowitz FD; Bristow MR J Am Coll Cardiol; 1995 May; 25(6):1225-31. PubMed ID: 7722114 [TBL] [Abstract][Full Text] [Related]
7. The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta-blocker trials? Otterstad JE; Ford I Eur J Heart Fail; 2002 Aug; 4(4):501-6. PubMed ID: 12167391 [TBL] [Abstract][Full Text] [Related]
8. Value of carvedilol in congestive heart failure secondary to coronary artery disease. Das Gupta P; Broadhurst P; Raftery EB; Lahiri A Am J Cardiol; 1990 Nov; 66(15):1118-23. PubMed ID: 1977300 [TBL] [Abstract][Full Text] [Related]
9. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group. Lancet; 1997 Feb; 349(9049):375-80. PubMed ID: 9033462 [TBL] [Abstract][Full Text] [Related]
10. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial. Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S; Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332 [TBL] [Abstract][Full Text] [Related]
11. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group. Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653 [TBL] [Abstract][Full Text] [Related]
12. Effects of a new vasodilating beta-blocking drug, carvedilol, on left ventricular function in stable angina pectoris. Lahiri A; Rodrigues EA; Al-Khawaja I; Raftery EB Am J Cardiol; 1987 Apr; 59(8):769-74. PubMed ID: 2881480 [TBL] [Abstract][Full Text] [Related]
13. Effects of carvedilol on left ventricular regional wall motion in patients with heart failure caused by ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group. Doughty RN; Whalley GA; Gamble G; MacMahon S; Sharpe N J Card Fail; 2000 Mar; 6(1):11-8. PubMed ID: 10746814 [TBL] [Abstract][Full Text] [Related]
14. Lack of evidence for peripheral alpha(1)- adrenoceptor blockade during long-term treatment of heart failure with carvedilol. Kubo T; Azevedo ER; Newton GE; Parker JD; Floras JS J Am Coll Cardiol; 2001 Nov; 38(5):1463-9. PubMed ID: 11691524 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of carvedilol in patients with chronic heart failure receiving concomitant amiodarone therapy. Australia/New Zealand Heart Failure Research Collaborative Group. Krum H; Shusterman N; MacMahon S; Sharpe N J Card Fail; 1998 Dec; 4(4):281-8. PubMed ID: 9924849 [TBL] [Abstract][Full Text] [Related]
16. Comparison of safety and efficacy of carvedilol and metoprolol in stable angina pectoris. van der Does R; Hauf-Zachariou U; Pfarr E; Holtbrügge W; König S; Griffiths M; Lahiri A Am J Cardiol; 1999 Mar; 83(5):643-9. PubMed ID: 10080412 [TBL] [Abstract][Full Text] [Related]
17. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure. Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865 [TBL] [Abstract][Full Text] [Related]
18. Effects of carvedilol on ventricular arrhythmias. Senior R; Müller-Beckmann B; DasGupta P; van der Does R; Lahiri A J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S117-21. PubMed ID: 1378137 [TBL] [Abstract][Full Text] [Related]
19. Tolerability and efficacy of carvedilol in patients with New York Heart Association class IV heart failure. Macdonald PS; Keogh AM; Aboyoun CL; Lund M; Amor R; McCaffrey DJ J Am Coll Cardiol; 1999 Mar; 33(4):924-31. PubMed ID: 10091817 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol. Metra M; Giubbini R; Nodari S; Boldi E; Modena MG; Dei Cas L Circulation; 2000 Aug; 102(5):546-51. PubMed ID: 10920067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]